홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
SMMT
#666
Summit Therapeutics Inc. Common Stock
20.850
0
USD
+4.09%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+4.09%
월간 변동
+29.66%
6달 변화
+4.98%
년간 변동율
+4.98%
이전 종가
20.030
0
Open
20.850
0
Bid
Ask
Low
20.850
0
High
20.850
0
양
80
마켓
주식
헬스케어
SMMT
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
82.92 M
98.12 M
697.69 M
701.7 M
737.68 M
775.37 M
—
Valuation ratios
Enterprise value
323.29 M
192.16 M
3.14 B
1.88 B
13.06 B
13.34 B
58.1 B
Price to earnings ratio
-6.18
-2.8
-12.2
-2.67
-57.56
-12.15
-106.61
Price to sales ratio
379.96
137.16
1 371.18
—
—
-21.44 K
-242.26 K
Price to cash flow ratio
-6.79
-3.42
-23.25
-21.31
-90.23
-40.5
-253.14
Price to book ratio
4.11
2.98
7.63
21.06
32.98
19.85
53.73
EBITDA 비율에 대한 기업 가치
-4.56
-1.82
-36.83
-3.08
-57.11
-12.1
-103.67
Profitability ratios
Return on assets %
-0.51
-0.78
-0.12
-3.03
-0.51
-1.44
-3.09
Return on equity %
-0.66
-1.06
-0.62
-7.91
-0.57
-1.64
-3.9
Return on invested capital %
-825.22
-1 235.77
-172.33
-1 492.71
-3 507.86
-10.84 K
—
Gross margin %
100
100
100
—
—
100
400
Operating margin %
-6 185.23
-4 764.29
-10.23 K
—
—
179.51 K
458.89 K
EBITDA margin %
-8 250.35
-5 848.92
-12.09 K
—
—
180.64 K
458.64 K
Net margin %
-6 127.56
-4 897.84
-11.17 K
—
—
176.98 K
456.03 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
4.41
3.8
16.93
9.3
10.15
9.87
29.42
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0.02
0
0
0
-0
-0
Solvency ratios
Debt to assets ratio
—
—
—
0.49
0
—
—
Debt to equity ratio
—
—
—
1.29
0
—
—
Long term debt to total assets ratio
—
—
—
0.49
0
—
—
Long term debt to total equity ratio
—
—
—
1.29
0
—
—
Per share metrics
Operating cash flow per share
-0.69
-0.79
-0.22
-0.12
-0.2
-0.43
-0.43
EBIT per share
-1.04
-1.16
-0.45
-0.99
-0.31
-1.46
-1.47
EBITDA per share
-1.02
-1.15
-0.44
-0.99
-0.32
-1.47
-1.48
Total debt per share
—
—
—
0.16
0
—
—
Cash per share
0.96
0.78
1.8
0.3
0.57
0.95
2.17
Net current asset value per share
1.26
1.05
3.4
0.31
0.59
0.96
2.21
Tangible book value per share
0.95
0.77
0.65
0.12
0.54
0.88
1.94
Working capital per share
0.97
0.78
3.2
0.27
0.53
0.87
1.9
Book value per share
1.14
0.9
0.66
0.13
0.54
0.88
1.96
뉴스
Why Is Ironwood (IRWD) Down 13.9% Since Last Earnings Report?
Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)
제프리스, Summit Therapeutics 투자의견 하향…임상 시험 리스크 반영
Jefferies downgrades Summit Therapeutics stock rating on trial risks
Micron and Facebook among market cap stock movers on Friday
서밋 테라퓨틱스, 시민 생명과학 컨퍼런스에서 Ivonescimab 전략 발표
Summit Therapeutics at The Citizens Life Sciences Conference: Strategic Insights on Ivonescimab
Summit Therapeutics Inc. (SMMT) Presents at The Citizens Life Sciences Conference 2026 Transcript
Summit Therapeutics, 이보네시맙 전략 집중 논의
Summit Therapeutics at TD Cowen Conference: Strategic Focus on Ivonesimab
RVMD Reports Wider-Than-Expected Q4 Loss, Issues 2026 Expense View
H.C. 웨인라이트, 서밋 테라퓨틱스 목표가 하향… 이유는?